FDA Left Out Of $80M For Stopping Consumer Product Fraud In Latest US COVID-19 Relief Act
American Rescue Plan Act appropriated $50m to Consumer Product Safety Commission and $30.4m to Federal Trade Commission for COVID-19-related enforcement. Neither agency received funding for pandemic-related enforcement in previous relief packages.
You may also be interested in...
Consumers Vulnerable To False Supplement Claims, Plus Products For ‘Gym Rats’ Get US DoJ Attention
DoJ criminal prosecutions in supplement sector have focused on undisclosed steroids targeted for consumers typically aware the products contain more than labels indicate. But weighing consumers’ vulnerability to false claims also factors in federal prosecutors’ decisions on seeking criminal charges in consumer health products sector.
US COVID-19 Relief Package Boosts Pharma Manufacturing Programs – More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.
Congress Gives FDA Authority To Destroy Counterfeit Devices Found In Imports
Safeguarding Therapeutics Act, approved by the House in September and by the Senate on 8 December, targets the proliferation of shipments into the US containing fake testing kits, cures and vaccines that claim to address coronavirus, some available OTC.